Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 26, 2481-2484, December 1, 1966]
© 1966 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, S.

The Effect of 1, 3-Bis(2-chloroethyl)-1-nitrosourea on Nicotinamide Adenine Dinucleotide Glycohydrolase of Mouse and Rat Neoplastic and Normal Tissues1

Saul Green

Division of Biochemistry, Sloan-Kettering Institute for Cancer Research, and Sloan-Kettering Division of Cornell University Graduate School of Medical Sciences, New York, New York

The effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on the nicotinamide adenine dinucleotide glycohydrolase (NADase) activity of mouse and rat neoplastic tissue has been studied and the results compared with those previously reported for nitrogen mustard. The experimental tumors used were: in mice, Ehrlich ascites carcinoma, Sarcoma 180 (solid and ascites), and Taper liver tumor (solid and ascites); in rats, Walker carcinosarcoma 256, Murphy-Sturm lymphosarcoma, and THF thyroid tumor. Tissues taken from BCNU-treated and -untreated animals were liver, kidney, lung, spleen, intestine, and brain. The sensitivity of tumors to BCNU varied; for a 50% or more inhibition in growth, solid tumors required about twice as much of the agent as the ascitic tumors. BCNU increased the NADase activity in all the tumors tested when it was administered to the host animals during the period of active tumor growth. No increase in the activity of this enzyme was found in any of the non-neoplastic tissues.

1 This investigation was supported in part by the following: Grant CA-08748 from the National Cancer Institute, NIH, and Grant P-164 from the American Cancer Society. The author was the recipient of a Research Career Development Award No. 5-K3-CA-19 453.

Received 3/ 7/66. Accepted 6/28/66.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1966 by the American Association for Cancer Research.